Effect of Passive Smoking on Orofacial Dysfunction Among a Group of Egyptian Children: A Cohort Study
NCT ID: NCT05678153
Last Updated: 2023-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2023-05-01
2023-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Mucosal Lesions Among Smokers in an Egyptian Population.
NCT03299595
Oral Mucosal Lesions Among Smokers in an Egyptian Population Study.
NCT03299634
Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population
NCT04391881
Oral Symptoms of COVID-19 Among Infected Medical Doctors
NCT05697081
Salivary Markers in Patients With Xerostomia
NCT03156569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After obtaining the informed consent, the investigator will fill an administrative questionnaire, which includes parents and child's personal data, medical and dental history, a question inquiring if one of the parents smokes in the house, the frequency of smoking, smoking type, and number of cigarettes (if present).
Then, the examination of orofacial dysfunction will be evaluated by the investigator, using Nordic Orofacial Test - screen (NOT-S)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
passive smokers children group (study group)
children whose parents reported having one or more family members smokes indoors in the presence of the child
Nordic Orofacial Test-Screen (NOT-S)
screening tool to detect orofacial dysfunction
non-passive smokers children group (control group)
children whose parents reported not to have one or more family members smokes indoors in the presence of the child
Nordic Orofacial Test-Screen (NOT-S)
screening tool to detect orofacial dysfunction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nordic Orofacial Test-Screen (NOT-S)
screening tool to detect orofacial dysfunction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children whose families accept to participate in this study.
Exclusion Criteria
4 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahram Canadian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mennat Allah Ashraf A.Elsabour
Primary investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mennat Allah Abd-Elsabour, Master
Role: PRINCIPAL_INVESTIGATOR
Ahram Canadian University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACU 222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.